By expenditures
| Name | Title | Type |
|---|---|---|
| Erin Thompson | Chief Financial Officer | Auditee |
| Elaine Morgan | DIRECTOR OF FINANCE AND BENEFITS | Auditee |
| Kristen Hughes | Managing Director | Auditee |
| Brian Welch | Managing Member | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 376372 | 2025 | 2025-12-19 | RSM US LLP | $50.60M |
| 336795 | 2024 | 2025-01-09 | Rsm US LLP | $88.26M |
| 13625 | 2023 | 2024-01-25 | Rsm US LLP | $68.36M |
| 35893 | 2022 | 2023-01-02 | Rsm US LLP | $67.67M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 376372 | 2025 | 2025-12-19 | 1165677 | 2025-002 | Material Weakness | Yes | N |
| 376372 | 2025 | 2025-12-19 | 1165676 | 2025-003 | Material Weakness | Yes | AB |
| 376372 | 2025 | 2025-12-19 | 1165675 | 2025-003 | Material Weakness | Yes | AB |
| 336795 | 2024 | 2025-01-09 | 1094864 | 2024-001 | Material Weakness | - | A |
| 336795 | 2024 | 2025-01-09 | 1094863 | 2024-001 | Material Weakness | - | A |
| 336795 | 2024 | 2025-01-09 | 1094862 | 2024-001 | Material Weakness | - | A |
| 336795 | 2024 | 2025-01-09 | 518422 | 2024-001 | Material Weakness | - | A |
| 336795 | 2024 | 2025-01-09 | 518421 | 2024-001 | Material Weakness | - | A |
| 336795 | 2024 | 2025-01-09 | 518420 | 2024-001 | Material Weakness | - | A |
| 35893 | 2022 | 2023-01-02 | 614630 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 614629 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 614628 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 614627 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 614626 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 614625 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 614624 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 614623 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 614622 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 614621 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 614620 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 614619 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 614618 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 614617 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 614616 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 614615 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 38188 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 38187 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 38186 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 38185 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 38184 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 38183 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 38182 | 2022-003 | Material Weakness | - | N |
| 35893 | 2022 | 2023-01-02 | 38181 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 38180 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 38179 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 38178 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 38177 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 38176 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 38175 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 38174 | 2022-002 | Significant Deficiency | - | N |
| 35893 | 2022 | 2023-01-02 | 38173 | 2022-003 | Material Weakness | - | N |